Appointment of Members of Senior Executive Service Performance Review Board, 43608 [2020-15491]
Download as PDF
<![CDATA[
43608
Federal Register / Vol. 85, No. 138 / Friday, July 17, 2020 / Notices
Dated: July 14, 2020.
Stefanie Davis,
Senior Assistant General Counsel.
Engagement
—Deliberations on any Findings and
Recommendations
—Other UAG Business and Work Plan
Schedule; Closing Remarks
In accordance with 41 CFR parts 101–
6 and 102–3, Federal Advisory
Committee Management; Final Rule,
Section 102–3.150(b), this meeting is
being held with less than 15 calendar
days’ notice to accommodate the
scheduling priorities of the key
participants.
[FR Doc. 2020–15493 Filed 7–16–20; 8:45 am]
BILLING CODE 7050–01–P
NATIONAL AERONAUTICS AND
SPACE ADMINISTRATION
[Notice: (20–062)]
National Space Council Users’
Advisory Group; Meeting
Patricia Rausch,
Advisory Committee Management Officer,
National Aeronautics and Space
Administration.
National Aeronautics and
Space Administration (NASA).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, as
amended, the National Aeronautics and
Space Administration (NASA)
announces a meeting of the National
Space Council Users’ Advisory Group
(UAG). This will be the fifth meeting of
the UAG.
DATES: Thursday, July 30, 2020, from
10:00 a.m.–1:00 p.m., Eastern Time.
ADDRESSES: Virtual meeting via dial-in
teleconference and WebEx only.
FOR FURTHER INFORMATION CONTACT: As
noted above, this meeting will be
available telephonically and by WebEx
only. You must use a touch-tone phone
to participate in this meeting. Any
interested person may dial the USA tollfree conference call number 1–844–467–
4685 or toll number 1–720–259–7012,
passcode 106724#, to participate in this
meeting by telephone. The WebEx link
is https://nasaenterprise.webex.com/;
the meeting number is 199 379 7435,
and password is tHiRkEk@574. To help
facilitate public input in this all-virtual
event, we invite appropriate written
submissions to the UAG public email
address at: contact@
spacecounciluag.org, in addition to
verbal input during the event.
The agenda for the meeting will
include the following:
—Opening Remarks and Meeting
Objectives by UAG Chair
—Expert Presentation on ‘‘Contributions
of Historically Black Colleges and
Universities (HBCUs) to Science,
Engineering, and the Space
Workforce’’
—Reports and Updates from UAG
Subcommittees:
• Exploration and Discovery
• National Security Space
• Technology and Innovation
• Economic Development/Industrial
Base
• Outreach and Education
• Space Policy and International
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:12 Jul 16, 2020
Jkt 250001
[FR Doc. 2020–15510 Filed 7–16–20; 8:45 am]
BILLING CODE 7510–13–P
EXECUTIVE OFFICE OF THE
PRESIDENT
Office of National Drug Control Policy
& DATE: Wednesday, July 22, 2020
from 2:30–3:30 p.m. EDT.
PLACE: This meeting will be held by
teleconference through the National
Science Foundation.
STATUS: Closed.
MATTERS TO BE CONSIDERED: The agenda
of the teleconference is: Committee
Chair’s Opening Remarks; Discussion of
NSF’s Fiscal Year 2022 budget
submission to the Office of Management
and Budget.
CONTACT PERSON FOR MORE INFORMATION:
Point of contact for this meeting is:
Chris Blair, telephone: (703) 292–7000.
Meeting information and updates may
be found at https://www.nsf.gov/nsb/
meetings/notices.jsp#sunshine. Please
refer to the National Science Board
website www.nsf.gov/nsb for general
information.
TIME
Chris Blair,
Executive Assistant to the National Science
Board Office.
[FR Doc. 2020–15613 Filed 7–15–20; 11:15 am]
Appointment of Members of Senior
Executive Service Performance Review
Board
BILLING CODE 7555–01–P
Office of National Drug Control
Policy (ONDCP).
ACTION: Notice of appointments.
NUCLEAR REGULATORY
COMMISSION
AGENCY:
The following persons have
been appointed to the ONDCP Senior
Executive Service Performance Review
Board: Ms. Martha Gagne´ (as Chair), Mr.
Kemp Chester, Mr. Eric Talbot, and Dr.
Terry Zobeck.
FOR FURTHER INFORMATION CONTACT:
Please direct any questions to Michael
Passante, Acting General Counsel, (202)
395–6709, Office of National Drug
Control Policy, Executive Office of the
President, Washington, DC 20503.
SUMMARY:
[NRC–2020–0001]
Sunshine Act Meetings
Weeks of July 20, 27,
August 3, 10, 17, 24, 31, September 7,
14, 21, 28, October 5, 12, 19, 2020.
PLACE: Commissioners’ Conference
Room, 11555 Rockville Pike, Rockville,
Maryland.
STATUS: Public.
TIME AND DATE:
Week of July 20, 2020
Dated: July 14, 2020.
Michael Passante,
Acting General Counsel.
There are no meetings scheduled for
the week of July 20, 2020.
[FR Doc. 2020–15491 Filed 7–16–20; 8:45 am]
There are no meetings scheduled for
the week of July 27, 2020.
Week of July 27, 2020—Tentative
BILLING CODE 3280–F5–P
Week of August 3, 2020—Tentative
NATIONAL SCIENCE FOUNDATION
There are no meetings scheduled for
the week of August 3, 2020.
Sunshine Act Meeting
Week of August 10, 2020—Tentative
The National Science Board’s Strategy
Committee, pursuant to NSF regulations
(45 CFR part 614), the National Science
Foundation Act, as amended (42 U.S.C.
1862n–5), and the Government in the
Sunshine Act (5 U.S.C. 552b), hereby
gives notice of the scheduling of a
teleconference for the transaction of
National Science Board business, as
follows:
There are no meetings scheduled for
the week of August 10, 2020.
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
Week of August 17, 2020—Tentative
There are no meetings scheduled for
the week of August 17, 2020.
Week of August 24, 2020—Tentative
There are no meetings scheduled for
the week of August 24, 2020.
E:\FR\FM\17JYN1.SGM
17JYN1
]]>Agencies
[Federal Register Volume 85, Number 138 (Friday, July 17, 2020)]
[Notices]
[Page 43608]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-15491]
=======================================================================
-----------------------------------------------------------------------
EXECUTIVE OFFICE OF THE PRESIDENT
Office of National Drug Control Policy
Appointment of Members of Senior Executive Service Performance
Review Board
AGENCY: Office of National Drug Control Policy (ONDCP).
ACTION: Notice of appointments.
-----------------------------------------------------------------------
SUMMARY: The following persons have been appointed to the ONDCP Senior
Executive Service Performance Review Board: Ms. Martha Gagn[eacute] (as
Chair), Mr. Kemp Chester, Mr. Eric Talbot, and Dr. Terry Zobeck.
FOR FURTHER INFORMATION CONTACT: Please direct any questions to Michael
Passante, Acting General Counsel, (202) 395-6709, Office of National
Drug Control Policy, Executive Office of the President, Washington, DC
20503.
Dated: July 14, 2020.
Michael Passante,
Acting General Counsel.
[FR Doc. 2020-15491 Filed 7-16-20; 8:45 am]
BILLING CODE 3280-F5-P
